Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3.12%-3.14M | 54.80%-1.41M | 54.29%-3.05M | 55.15%-3.11M | 4.80%-23.23M | -4.87M | 14.26%-4.76M | -3.65%-6.66M | -46.79%-6.93M | -81.71%-24.4M |
| Net income from continuing operations | 42.31%-3.39M | 133.97%2.44M | 44.52%-5.87M | 35.35%-7.19M | -11.88%-39.9M | ---7.01M | -103.04%-11.18M | 4.19%-10.58M | -24.68%-11.13M | -51.47%-35.67M |
| Operating gains losses | -73.68%303.03K | -254.78%-2.3M | 171.54%1.15M | --1.49M | --975.46K | ---561.84K | --2.94M | ---1.61M | ---- | ---- |
| Depreciation and amortization | 7.63%75.25K | 9.62%77.33K | 128.82%69.92K | 146.32%70.55K | 222.78%297.17K | --205.26K | 42.36%32.72K | 35.43%30.55K | 27.70%28.64K | 170.28%92.07K |
| Unrealized gains and losses of investment securities | 314.10%450.83K | ---625.9K | ---210.57K | --0 | ---- | ---- | ---210.57K | ---- | ---- | ---- |
| Remuneration paid in stock | -96.47%64.51K | -107.13%-144.75K | -55.50%1.83M | -56.59%2.03M | 27.31%15.99M | --3.57M | 75.75%3.64M | 46.45%4.1M | 35.55%4.68M | 2.23%12.56M |
| Other non cashItems | -38.88%1.92K | 101.93%2.23K | -47.66%3.13K | 4.71%-115.82K | 280.68%229.29K | --15.47K | 160.86%19.54K | -84.17%5.99K | -15.26%-121.55K | -367.48%-126.9K |
| Change In working capital | -382.21%-649.1K | -239.85%-853.53K | -112.50%-134.61K | 256.07%610.32K | 35.04%-820.77K | ---1.51M | 100.24%5.04K | -38.55%1.08M | -146.93%-391.06K | 43.91%-1.26M |
| -Change in receivables | 37.34%-28.74K | -104.89%-30.67K | -4.99%-45.87K | 5,676.33%627.67K | -10.33%-215.24K | ---130.63K | 68.07%-29.66K | 80.82%-43.69K | -111.36%-11.26K | -380.79%-195.09K |
| -Change in prepaid assets | 92.16%-37.35K | -45.01%259.74K | -218.38%-476.57K | 178.34%472.34K | 72.28%-338.2K | ---665.14K | 1,564.64%527.3K | 556.13%402.58K | -339.08%-602.95K | -105.34%-1.22M |
| -Change in payables and accrued expense | -250.33%-583.01K | -151.95%-1.08M | -27.90%387.83K | -292.56%-429.69K | -315.69%-327.33K | ---655.81K | 78.12%-432.6K | -73.99%537.93K | -53.70%223.15K | 108.78%151.76K |
| -Change in other working capital | ---- | ---- | ---- | ---60K | --60K | ---60K | ---60K | --180K | ---- | ---- |
| Interest received (cash flow from operating activities) | ---- | ---- | -61.52%119.24K | ---- | ---- | ---- | ---- | --309.84K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3.12%-3.14M | 54.80%-1.41M | 54.29%-3.05M | 55.15%-3.11M | 4.80%-23.23M | ---4.87M | 14.26%-4.76M | -3.65%-6.66M | -46.79%-6.93M | -81.71%-24.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 1.12M | 582.6K | 0 | 0 | 602.08%22.26M | 3.71M | -112.14%-1.97M | 443.91%15.82M | 8,433.84%4.69M | 109.47%3.17M |
| Capital expenditure reported | ---- | ---- | --0 | ---- | 95.64%-201.65K | --0 | --0 | 95.62%-201.65K | ---- | -1,652.26%-4.63M |
| Net PPE purchase and sale | ---- | ---- | --0 | --0 | -2,836.22%-518.57K | ---289.95K | --0 | ---78.4K | -1,436.39%-150.21K | 57.15%-17.66K |
| Net business purchase and sale | --0 | --249.02K | --0 | --0 | ---5.36M | --0 | --0 | ---5.36M | ---- | --0 |
| Net investment purchase and sale | --1.12M | --333.58K | --0 | --0 | 266.20%28.34M | --4M | -112.14%-1.97M | --21.46M | --4.84M | 121.49%7.74M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 114.03%77.76K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --1.12M | --582.6K | --0 | --0 | 602.08%22.26M | --3.71M | -112.14%-1.97M | 443.91%15.82M | 8,433.84%4.69M | 109.47%3.17M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 72,966.16%9.28M | -572.44%-12.74K | -243.10%-12.74K | -100.24%-1.89K | -94.07%758.15K | -20.41K | -107.15%-24.57K | 101.58%8.9K | -61.90%794.24K | -79.11%12.79M |
| Net issuance payments of debt | 0.00%-12.74K | 0.00%-12.74K | 36.90%-12.74K | 47.77%-12.74K | 92.09%-89.78K | ---20.63K | -419.10%-24.57K | 98.08%-20.19K | -195.91%-24.39K | -79.37%-1.14M |
| Net common stock issuance | --9.29M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -98.68%10.84K | -93.91%847.93K | --220 | --0 | -94.05%29.09K | -60.89%818.62K | -5.18%13.93M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 72,966.16%9.28M | -572.44%-12.74K | -243.10%-12.74K | -100.24%-1.89K | -94.07%758.15K | ---20.41K | -107.15%-24.57K | 101.58%8.9K | -61.90%794.24K | -79.11%12.79M |
| Net cash flow | ||||||||||
| Beginning cash position | -95.95%363K | -90.66%1.11M | -15.00%8.97M | -0.80%11.89M | -39.15%11.99M | --13.06M | 238.53%19.8M | -38.15%10.55M | -39.15%11.99M | 257.75%19.7M |
| Current changes in cash | 337.52%7.26M | 73.15%-835.36K | -133.35%-3.06M | -115.35%-3.11M | 97.46%-214.26K | ---1.18M | -161.34%-6.75M | 179.10%9.17M | 44.07%-1.44M | -158.91%-8.44M |
| Effect of exchange rate changes | 100.24%439 | -52.62%88.34K | -314.35%-180.58K | 3,182.87%186.43K | -83.79%117.91K | --9.16K | -59.50%18.82K | -78.33%84.25K | 108.80%5.68K | 640.28%727.43K |
| End cash Position | 33.17%7.63M | -95.95%363K | -71.08%5.73M | -15.00%8.97M | -0.80%11.89M | --11.89M | -22.72%13.06M | 238.53%19.8M | -38.15%10.55M | -39.15%11.99M |
| Free cash from | -3.12%-3.14M | 54.80%-1.41M | 56.14%-3.05M | 56.10%-3.11M | 17.55%-23.95M | ---5.16M | 14.26%-4.76M | 37.05%-6.94M | -49.66%-7.08M | -111.49%-29.05M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.